Dr. Nemecek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-494-0829Fax+1 503-494-0714
Education & Training
- Oregon Health & Science University/Portland State UniversityMBA, Healthcare Management, 2010 - 2013
- Oregon Health & Science UniversityM.B.A., Healthcare Management, 2010 - 2013
- University of WashingtonM.S., Epidemiology, 2002 - 2004
- University of WashingtonM.Sc., Epidemiology and Clinical Research, 2002 - 2004
- University of WashingtonFellowship, Pediatric Hematology/Oncology, 1999 - 2002
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1996 - 1999
- University of Puerto Rico School of MedicineClass of 1996
- University of Puerto RicoB.S., Biology, Magna Cum Laude, 1989 - 1993
Certifications & Licensure
- WA State Medical License 1998 - 2026
- OR State Medical License 2005 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Clinical Research Scholar, One of Three Institutional Recipients Knight Cancer Institute, 2012
- Featured in article in Portland Family Magazine Medical Mamas, 2012
- Top Doctors U.S. News and World Report, 2012
- Join now to see all
Clinical Trials
- Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia Start of enrollment: 1999 Feb 01
- Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
- Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome Start of enrollment: 2005 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsProceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop.Jeffery J Auletta, Jennifer Holter-Chakrabarty, Pashna Munshi, Sarah Wall, Nandita Khera
Transplantation and Cellular Therapy. 2024-12-01 - Ibrutinib for therapy of steroid-refractory chronic graft vs. host disease: A multicenter real-world analysis.Joseph A Pidala, Jongphil Kim, Denise Kalos, Corey S Cutler, Zachariah DeFilipp
Blood Advances. 2024-10-25 - Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma.Somya Khare, Staci Williamson, Brittany O'Barr, Levanto Schachter, Andy Chen
Clinical Lymphoma, Myeloma & Leukemia. 2024-09-27
Journal Articles
- Genetic Mechanisms of Target Antigen Loss in CAR19 Therapy of Acute Lymphoblastic LeukemiaJohn E Levine, Muna Qayed, Stephan A Grupp, Eneida R Nemecek, Stella M Davies, Michael R Verneris, Michael Boyer, Jeffrey A Engelman, Nature
- A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica
- The genomic landscape of juvenile myelomonocytic leukemiaStieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen SR, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA..., Nature Genetics 2015 Nov;47(11):1326-33
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) Following Solid Organ (SOT) or Allogeneic Hematop...Eneida R. Nemecek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease.Kurtzberg J, Prockop S, Prasad VK, Chaudhury S, Teira P, Nemecek ER, Horn B, Burke E, Hayes J, Skerrett D, Biol Blood Marrow Transplant; BMT Tandem Meetings, 1/1/2015
- A preliminary population pharmacokinetic model for dose selection of treosulfan used in conditioning treatment prior to haematopoietic stem cell transplantation in chi...Van Den Berg PJ, Ruppert M, Sykora KW, Beier R, Beelen DW, Hilger RA, Scheulen ME, Wachowiak J, Nemecek ER, Spaans E, Lioznov M, Pichlmeier U, Wullf B, Baumgart J, 40th Annual Congress of the European Group for Blood and Marrow Transplantation, Milan, Italy, 1/1/2014
- Join now to see all
Lectures
- The changing spectrum of Pediatric BMTPortland, OR - 1/17/2015
- Extracorporeal Photopheresis in ChildrenVienna, Austria - 1/18/2013
- Cancer and Blood Disorders-Basics for the Naturopathic DoctorNational College of Naturopathic Medicine, Portland, OR - 1/18/2013
- Join now to see all
Other
- Newborn screening program for severe combined immunodeficiency. CD SummarySkeels M, Shereck E, Nemecek ER, Oregon Public Health Division, Oregon Health Authority
http://public.health.oregon.gov/DiseasesConditions/CommunicableDisease/CDSummaryNewsletter/Documents/2014/ohd6316.pdf
1/1/2014 - When stem cell transplantation becomes preventive Medicine: Early diagnosis and treatment of primary immunodeficiencies.Kurre P, Nemecek ER, The Hematologist, ASH News and Reports
http://www.hematology.org/Thehematologist
1/1/2014 - Hematopoietic stem cell transplantation for people with sickle cell disease.Oringanje C, Nemecek ER, Oniyangi O, Cochrane Database Syst Rev
1/31/2013 - Join now to see all
Press Mentions
- OHSU Knight Cancer Institute Gets Grant to Build Equity in Clinical TrialsMarch 15th, 2023
- Oregon Health and Science University Makes Strides Increasing Diversity in Clinical StudiesJanuary 4th, 2023
Committees
- Chair, National Marrow Donor Program - Diversity and Healthcare Disparities Advisory Group 2014 - Present
- Member, American Society of Hematology - Committee on Promoting Diversity 2014 - Present
- Co-Chair, OHSU Knight Cancer Institute - Clinical Research Review Committee 2012 - Present
- Member, National Marrow Donor Program-Cord Blood Advisory Group 2011 - Present
- Pediatric Liaison, Blood & Marrow Transplant Clinical Trials Network - Steering Committee 2010 - Present
- Member, Pediatric BMT Consortium - Executive & Steering Committees 2010 - Present
- Member, National Marrow Donor Program- Donor & Patient Safety Monitoring Committee 2011 - 2015
- Director Member, National Marrow Donor Program- Board of Directors 2010 - 2015
Professional Memberships
- Member
- Member
- Member
- American Society for Blood and Marrow TransplantationMember
- Society for Pediatric ResearchMember
- Cord Blood AssociationMember
- Pediatric Blood and Marrow Transplant ConsortiumMember
Other Languages
- Spanish
External Links
- Pediatric BMT at Doernbecher Children's Hospitalhttp://www.ohsu.edu/xd/health/services/doernbecher/programs-services/cancer/index.cfm
- OHSU Knight Cancer Institute BMT Programhttp://www.ohsu.edu/xd/health/services/cancer/getting-treatment/services/bone-marrow-transplant
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: